Sophrosyne Capital’s Itron ITRI Stock Holding History

Sophrosyne Capital’s Portfolio ITRI Stock Details ITRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-5,800	Closed	-$240K	–	84
2013 Q4	$240K	Buy	+5,800	New	+$246K	0.21%	48

Other funds holding ITRI

Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Sophrosyne Capital's ITRI Position: Q1 2014 in Review

Sophrosyne Capital sold out of Itron (ITRI) in Q1 2014, closing a stake of 5,800 shares — an estimated $240K sold.

Sophrosyne Capital first reported a position in ITRI in Q4 2013 and held it in 1 quarter. The position peaked at $240K in Q4 2013. 207 funds tracked by Wall St. Rank hold ITRI as of Q1 2014.

Sophrosyne Capital reported no remaining Itron position as of Q1 2014 after selling out during the quarter.
Sophrosyne Capital sold 5,800 Itron shares in Q1 2014, an estimated $240K.
Sophrosyne Capital first reported a position in Itron in Q4 2013 and held it in 1 quarter.
Sophrosyne Capital's Itron position peaked at $240K in Q4 2013.
207 funds tracked by Wall St. Rank held Itron as of Q1 2014.

Based on Sophrosyne Capital's 13F filing for Q1 2014, filed 14 May 2014.